Among the 14687 participants in our study, there were 11547 people without SALI (78.62%) and 3140 (21.38%) with SALI. Compared with non-SALI, people with SALI were younger. Compared with males, females were more likely to have SALI. People with SALI were higher sore of sofa than people without SALI. (Table 1). Age was related with ICU mortality (RR, 1.02; 95% CI, 1.02, 1.03), 28-day mortality (RR, 1.03; 95% CI, 1.03, 1.04) and 1-year mortality (RR, 1.04; 95% CI, 1.03, 1.04). SALI had significantly positive association with ICU mortality (RR, 1.33; 95% CI, 1.30, 1.35), 28-day mortality (RR, 1.23; 95% CI, 1.22, 1.25) and 1-year mortality (RR, 1.16; 95% CI, 1.14, 1.17) (Table 2). As shown in Table 3, after adjusting for age, gender, SOFA score, APACHEIII score, urine output, mechanical ventilation, RRT, vasopressor use, solid tumor, diabetes, alcohol abuse, lactate, PLT, PTT, SALI was significantly positively associated with ICU mortality (RR, 1.54; 95% CI, 1.32, 1.79), 28-day mortality (RR, 1.27; 95% CI, 1.11, 1.45) and 1-year mortality (RR, 1.19; 95% CI, 1.06, 1.34) (Table 3). Stratified by SOFA, there was a positive association between SALI and ICU mortality (RR, 2.15; 95% CI, 1.64, 2.80), 28-day mortality (RR, 1.60; 95% CI, 1.28, 1.99), 1-year mortality (RR, 1.24; 95% CI, 1.04, 1.48) after adjusting confounding factors among people with sofa score ≤ 5. Similar results were also obtained between SALI and ICU mortality (RR,1.40; 95% CI, 1.17, 1.67), 28-day mortality (RR, 1.17; 95% CI, 0.99, 1.38), 1-year mortality (RR, 1.19; 95% CI, 1.02, 1.38) after adjusting confounding among people with sofa score > 5. Also, there was an interaction between total SOFA and SALI (Table 4). Compared with SOFA renal > 1, SALI had a stronger positive correlation with ICU mortality (RR, 1.36; 95% CI, 1.01, 1.84), 28-day mortality (RR, 1.19; 95% CI, 0.91, 1.56), 1-year mortality (RR, 1.11; 95% CI, 0.88, 1.41) after adjusted confounding factors among people with SOFA renal ≤ 1. Also, SOFA renal was interacted with SALI (Tables 5–7).
Table 1
Demographic and clinical characteristics of study cohort in MIMIC-III
Characteristic
|
Liver Function Group
|
P
|
Non-SALI group
|
SALI group
|
N (%)
|
11547 (78.62)
|
3140 (21.38)
|
|
Age (years)
|
69.76 ± 15.58
|
65.20 ± 16.81
|
< 0.001
|
Gender
|
|
|
< 0.001
|
Female
|
5715 (49.49)
|
1838 (58.54)
|
|
Male
|
5832 (50.51)
|
1302 (41.46)
|
|
SOFA score
|
4.72 ± 2.47
|
6.77 ± 3.52
|
< 0.001
|
Respiration
|
1.93 ± 1.29
|
2.18 ± 1.42
|
< 0.001
|
Renal
|
1.17 ± 1.31
|
1.29 ± 1.32
|
< 0.001
|
Cardiovascular
|
1.42 ± 1.13
|
1.93 ± 1.43
|
< 0.001
|
Cns
|
0.80 ± 1.08
|
0.69 ± 1.13
|
< 0.001
|
Coagulation
|
0.38 ± 0.72
|
0.78 ± 1.06
|
< 0.001
|
Liver
|
0.14 ± 0.40
|
0.96 ± 1.10
|
< 0.001
|
APACHEIII score
|
48.28 ± 18.35
|
57.81 ± 23.23
|
< 0.001
|
Urine output (mL)
|
1488.00 (882.75-2312.75)
|
1450.00 (798.50–2390.00)
|
0.044
|
Mechanical Ventilation
|
|
|
< 0.001
|
No
|
6507 (56.35)
|
1322 (42.10)
|
|
Yes
|
5040 (43.65)
|
1818 (57.90)
|
|
RRT
|
|
|
0.566
|
No
|
10831 (93.80)
|
2954 (94.08)
|
|
Yes
|
716 (6.20)
|
186 (5.92)
|
|
Vasopressor use
|
|
|
< 0.001
|
No
|
8033 (69.57)
|
1611 (51.31)
|
|
Yes
|
3514 (30.43)
|
1529 (48.69)
|
|
Solid tumor
|
|
|
0.729
|
No
|
11120 (96.30)
|
3028 (96.43)
|
|
Yes
|
427 (3.70)
|
112 (3.57)
|
|
Diabetes
|
|
|
< 0.001
|
No
|
7784 (67.41)
|
2305 (73.41)
|
|
Yes
|
3763 (32.59)
|
835 (26.59)
|
|
Alcohol abuse
|
|
|
< 0.001
|
No
|
11178 (96.80)
|
2967 (94.49)
|
|
Yes
|
369 (3.20)
|
173 (5.51)
|
|
Lactate (mmol/L)
|
1.70 (1.20–2.38)
|
2.27 (1.50–3.64)
|
< 0.001
|
PLT (K/µL)
|
224.83 (163.00-306.00)
|
187.00 (124.00-267.58)
|
< 0.001
|
PTT (s)
|
31.20 (26.95–38.70)
|
34.05 (28.55–46.60)
|
< 0.001
|
Values were median (IQR) or mean ± SD or n (%). |
The values of polytomous variables may not sum to 100% due to rounding. |
Abbreviations: RRT: renal replacement; PLT: platelet count; PTT: partial thromboplastin time. |
Table 2
Univariate analysis between characteristics of participants and mortality
Characteristics
|
Statistics
|
ICU Mortality, RR (95% CI)
|
28-day Mortality, RR (95% CI)
|
1-year Mortality, RR (95% CI)
|
Age (years)
|
68.79 ± 15.96
|
1.02 (1.02, 1.03)
|
1.03 (1.03, 1.04)
|
1.04 (1.03, 1.04)
|
Gender
|
|
|
|
|
Female
|
7553 (51.43)
|
1.0 (Reference)
|
1.0 (Reference)
|
1.0 (Reference)
|
Male
|
7134 (48.57)
|
1.004 (0.91, 1.11)
|
1.01 (0.93, 1.10)
|
0.94 (0.88, 1.01)
|
SOFA score
|
5.16 ± 2.85
|
1.33 (1.30, 1.35)
|
1.23 (1.22, 1.25)
|
1.16 (1.14, 1.17)
|
Respiration
|
1.99 ± 1.33
|
1.25 (1.19, 1.32)
|
1.14 (1.09, 1.19)
|
1.05 (1.01, 1.09)
|
Cardiovascular
|
1.53 ± 1.22
|
1.59 (1.53, 1.65)
|
1.34 (1.30, 1.39)
|
1.19 (1.16, 1.23)
|
Renal
|
1.19 ± 1.31
|
1.43 (1.38, 1.48)
|
1.34 (1.30, 1.38)
|
1.31 (1.27, 1.34)
|
Cns
|
0.78 ± 1.09
|
1.13 (1.08, 1.18)
|
1.25 (1.20, 1.29)
|
1.17 (1.14, 1.21)
|
Coagulation
|
0.46 ± 0.82
|
1.40 (1.33, 1.47)
|
1.29 (1.24, 1.35)
|
1.21 (1.16, 1.26)
|
Liver
|
0.40 ± 0.81
|
1.24 (1.15, 1.33)
|
1.19 (1.12, 1.26)
|
1.12 (1.06, 1.18)
|
APACHEIII score
|
50.32 ± 19.88
|
1.05 (1.04, 1.05)
|
1.04 (1.04, 1.04)
|
1.03 (1.03, 1.03)
|
Urine output (mL)
|
1480.00
(861.00, 2330.00)
|
0.999
(0.999, 0.999)
|
0.999
(0.999, 0.999)
|
0.999
(0.999, 0.999)
|
Mechanical Ventilation
|
|
|
|
|
No
|
7829 (53.31)
|
1.0 (Reference)
|
1.0 (Reference)
|
1.0 (Reference)
|
Yes
|
6858 (46.69)
|
2.53 (2.28, 2.82)
|
1.36 (1.25, 1.48)
|
1.05 (0.99, 1.13)
|
RRT
|
|
|
|
|
No
|
13785 (93.86)
|
1.0 (Reference)
|
1.0 (Reference)
|
1.0 (Reference)
|
Yes
|
902 (6.14)
|
1.36 (1.12, 1.64)
|
1.21 (1.03, 1.43)
|
1.67 (1.46, 1.91)
|
Vasopressor use
|
|
|
|
|
No
|
9644 (65.66)
|
1.0 (Reference)
|
1.0 (Reference)
|
1.0 (Reference)
|
Yes
|
5043 (34.34)
|
2.64 (2.38, 2.92)
|
1.66 (1.52, 1.80)
|
1.23 (1.15, 1.32)
|
Solid tumor
|
|
|
|
|
No
|
14148 (96.33)
|
1.0 (Reference)
|
1.0 (Reference)
|
1.0 (Reference)
|
Yes
|
539 (3.67)
|
1.44 (1.13, 1.82)
|
1.86 (1.54, 2.24)
|
2.49 (2.09, 2.97)
|
Diabetes
|
|
|
|
|
No
|
10089 (68.69)
|
1.0 (Reference)
|
1.0 (Reference)
|
1.0 (Reference)
|
Yes
|
4598 (31.31)
|
0.86 (0.77, 0.96)
|
0.87 (0.80, 0.96)
|
0.99 (0.92, 1.06)
|
Alcohol abuse
|
|
|
|
|
No
|
14145 (96.31)
|
1.0 (Reference)
|
1.0 (Reference)
|
1.0 (Reference)
|
Yes
|
542 (3.69)
|
0.58 (0.41, 0.80)
|
0.43 (0.32, 0.58)
|
0.35 (0.28, 0.43)
|
Lactate (mmol/L)
|
1.80 (1.30, 2.61)
|
1.40 (1.36, 1.44)
|
1.32 (1.28, 1.35)
|
1.20 (1.17, 1.23)
|
PLT (K/µL)
|
217.00
(154.00, 298.00)
|
0.999
(0.999, 0.9996)
|
0.999
(0.999, 1.0001)
|
1.0001
(0.999, 1.0003)
|
PTT (s)
|
31.80
(27.20, 40.20)
|
1.02
(1.01, 1.02)
|
1.01
(1.01, 1.01)
|
1.01
(1.01, 1.01)
|
Values were median (IQR) or mean ± SD or n (%). |
The values of polytomous variables may not sum to 100% due to rounding. |
Abbreviations: RRT: renal replacement; PLT: platelet count; PTT: partial thromboplastin time; RR: relative risk. |
Table 3
Relationship between liver function and mortality in different models
Exposure
|
Non-SALI
|
SALI, RR (95% CI)
|
ICU Mortality
|
|
|
Model Ia
|
1.0 (Reference)
|
3.35 (3.00, 3.74)
|
Model IIb
|
1.0 (Reference)
|
1.54 (1.32, 1.79)
|
28-day Mortality
|
|
|
Model Ia
|
1.0 (Reference)
|
2.20 (2.00, 2.42)
|
Model IIb
|
1.0 (Reference)
|
1.27 (1.11, 1.45)
|
1-year Mortality
|
|
|
Model Ia
|
1.0 (Reference)
|
1.70 (1.57, 1.85)
|
Model IIb
|
1.0 (Reference)
|
1.19 (1.06, 1.34)
|
aAdjust for Age(years). |
bAdjust for Age (years), Gender (Female, Male), SOFA score, APACHEIII score, Urine output (mL), Mechanical Ventilation (No, Yes), RRT (No, Yes), Vasopressor use (No, Yes), Solid tumor (No, Yes), Diabetes (No, Yes), Alcohol abuse (No, Yes), Lactate (mmol/L), PLT (K/µL), PTT (s). |
Table 4
Stratified analyses of between liver function and ICU mortality by sofa score
Exposure
|
SOFA score ≤ 5
|
SOFA score > 5
|
P for interaction
|
Non-SALI
|
SALI, RR (95% CI)
|
Non-SALI
|
SALI, RR (95% CI)
|
ICU Mortality
|
|
|
|
|
< 0.001
|
Model Ia
|
1.0 (Reference)
|
2.97 (2.45–3.61)
|
1.0 (Reference)
|
2.32 (2.02–2.66)
|
|
Model IIb
|
1.0 (Reference)
|
2.15 (1.64, 2.80)
|
1.0 (Reference)
|
1.40 (1.17, 1.67)
|
|
28-day Mortality
|
|
|
|
|
< 0.001
|
Model Ia
|
1.0 (Reference)
|
1.75 (1.49–2.06)
|
1.0 (Reference)
|
1.75 (1.54–1.99)
|
|
Model IIb
|
1.0 (Reference)
|
1.60 (1.28, 1.99)
|
1.0 (Reference)
|
1.17 (0.99, 1.38)
|
|
1-year Mortality
|
|
|
|
|
0.010
|
Model Ia
|
1.0 (Reference)
|
1.42 (1.25–1.61)
|
1.0 (Reference)
|
1.48 (1.32–1.67)
|
|
Model IIb
|
1.0 (Reference)
|
1.24 (1.04, 1.48)
|
1.0 (Reference)
|
1.19 (1.02, 1.38)
|
|
aAdjust for Age(years). |
bAdjust for Age (years), Gender (Female, Male), SOFA score, APACHEIII score, Urine output (mL), Mechanical Ventilation (No, Yes), RRT (No, Yes), Vasopressor use (No, Yes), Solid tumor (No, Yes), Diabetes (No, Yes), Alcohol abuse (No, Yes), Lactate (mmol/L), PLT (K/µL), PTT (s). Of note, the variables examined in this table were not adjusted. |
Table 5
Stratified analyses of between liver function and ICU mortality by sofa components
Exposure
|
Non-SALI
|
SALI, RR (95% CI)
|
P for interaction
|
Renal
|
|
|
0.041
|
≤ 1 (N = 10008)
|
1.0 (Reference)
|
1.36 (1.01, 1.84)
|
|
> 1 (N = 4672)
|
1.0 (Reference)
|
1.01 (0.71, 1.41)
|
|
Respiration
|
|
|
0.039
|
≤ 2 (N = 4235)
|
1.0 (Reference)
|
1.39 (0.98, 1.97)
|
|
> 2 (N = 3183)
|
1.0 (Reference)
|
1.03 (0.77, 1.38)
|
|
Coagulation
|
|
|
0.527
|
0 (N = 10193)
|
1.0 (Reference)
|
1.49 (1.12, 1.98)
|
|
> 0 (N = 4420)
|
1.0 (Reference)
|
0.82 (0.57, 1.18)
|
|
Cardiovascular
|
|
|
0.011
|
≤ 1 (N = 10845)
|
1.0 (Reference)
|
1.65 (1.17, 2.33)
|
|
> 1 (N = 3729)
|
1.0 (Reference)
|
0.89 (0.66, 1.20)
|
|
Cns
|
|
|
0.350
|
0 (N = 8072)
|
1.0 (Reference)
|
1.16 (0.88, 1.52)
|
|
> 0 (N = 6468)
|
1.0 (Reference)
|
1.14 (0.77, 1.70)
|
|
*Adjust for Age (years), Gender (Female, Male), Respiration, Renal, Cardiovascular, Cns, Coagulation, Liver, APACHEIII score, Urine output (mL), Mechanical Ventilation (No, Yes), RRT (No, Yes), Vasopressor use (No, Yes), Solid tumor (No, Yes), Diabetes (No, Yes), Alcohol abuse (No, Yes), Lactate (mmol/L), PLT (K/µL), PTT (s). Of note, the variables examined in this table were not adjusted. |
Table 6
Stratified analyses of between liver function and 28-day mortality by sofa components
Exposure
|
Non-SALI
|
SALI, RR (95% CI)
|
P for interaction
|
Renal
|
|
|
< 0.001
|
≤ 1 (N = 10008)
|
1.0 (Reference)
|
1.19 (0.91, 1.56)
|
|
> 1 (N = 4672)
|
1.0 (Reference)
|
0.91 (0.65, 1.26)
|
|
Respiration
|
|
|
0.234
|
≤ 2 (N = 4235)
|
1.0 (Reference)
|
1.12 (0.82, 1.53)
|
|
> 2 (N = 3183)
|
1.0 (Reference)
|
1.003 (0.76, 1.32)
|
|
Coagulation
|
|
|
0.214
|
0 (N = 10193)
|
1.0 (Reference)
|
1.23 (0.94, 1.60)
|
|
> 0 (N = 4420)
|
1.0 (Reference)
|
0.84 (0.60, 1.18)
|
|
Cardiovascular
|
|
|
0.379
|
≤ 1 (N = 10845)
|
1.0 (Reference)
|
1.46 (1.08, 1.99)
|
|
> 1 (N = 3729)
|
1.0 (Reference)
|
0.78 (0.59, 1.04)
|
|
Cns
|
|
|
0.013
|
0 (N = 8072)
|
1.0 (Reference)
|
1.11 (0.86, 1.43)
|
|
> 0 (N = 6468)
|
1.0 (Reference)
|
0.94 (0.65, 1.35)
|
|
*Adjust for Age (years), Gender (Female, Male), Respiration, Renal, Cardiovascular, Cns, Coagulation, Liver, APACHEIII score, Urine output (mL), Mechanical Ventilation (No, Yes), RRT (No, Yes), Vasopressor use (No, Yes), Solid tumor (No, Yes), Diabetes (No, Yes), Alcohol abuse (No, Yes), Lactate (mmol/L), PLT (K/µL), PTT (s). Of note, the variables examined in this table were not adjusted. |
Table 7
Stratified analyses of between liver function and 1-year mortality by sofa components
Exposure
|
Non-SALI
|
SALI, RR (95% CI)
|
P for interaction
|
Renal
|
|
|
0.008
|
≤ 1 (N = 10008)
|
1.0 (Reference)
|
1.11 (0.88, 1.41)
|
|
> 1 (N = 4672)
|
1.0 (Reference)
|
0.76 (0.55, 1.04)
|
|
Respiration
|
|
|
0.083
|
≤ 2 (N = 4235)
|
1.0 (Reference)
|
1.04 (0.79, 1.37)
|
|
> 2 (N = 3183)
|
1.0 (Reference)
|
0.89 (0.69, 1.16)
|
|
Coagulation
|
|
|
0.087
|
0 (N = 10193)
|
1.0 (Reference)
|
1.02 (0.81, 1.29)
|
|
> 0 (N = 4420)
|
1.0 (Reference)
|
0.89 (0.65, 1.23)
|
|
Cardiovascular
|
|
|
0.107
|
≤ 1 (N = 10845)
|
1.0 (Reference)
|
1.29 (0.99, 1.69)
|
|
> 1 (N = 3729)
|
1.0 (Reference)
|
0.70 (0.53, 0.92)
|
|
Cns
|
|
|
0.297
|
0 (N = 8072)
|
1.0 (Reference)
|
0.95 (0.75, 1.19)
|
|
> 0 (N = 6468)
|
1.0 (Reference)
|
1.01 (0.72, 1.40)
|
|
*Adjust for Age (years), Gender (Female, Male), Respiration, Renal, Cardiovascular, Cns, Coagulation, Liver, APACHEIII score, Urine output (mL), Mechanical Ventilation (No, Yes), RRT (No, Yes), Vasopressor use (No, Yes), Solid tumor (No, Yes), Diabetes (No, Yes), Alcohol abuse (No, Yes), Lactate (mmol/L), PLT (K/µL), PTT (s). Of note, the variables examined in this table were not adjusted. |
Abbreviations: ICU, intensive care unit; SALI, sepsis-associated liver injury. |